Not licensed to dispense sterile compounds, and not licensed generally, in California, Nevada, New Jersey, North Carolina, Texas, Massachusetts, Mississippi, New Hampshire, West Virginia, or Delaware
Key takeaways The first month is an adjustment month
This expanding science reinforces that GLP-1 medications arent just a fad they may be a foundational shift in treating chronic metabolic conditions
Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity
Activation of GLP-1R by GLP-1 or other exogenous agonists, including exendin-4 and liraglutide, decreases inflammatory responses in several animal models like rat heart and whole animal model
Primary antibodies targeted FOXO4, Leydig cell markers (StAR, CYP11A1, 3-HSD), spermatogenesis markers (PCNA, PLZF, UCHL1, SCP3), and senescence/apoptosis markers (Ser15-phospho-p53)